Stockreport

Merck raises guidance as Keytruda sales jump 20% in Q1 [Seeking Alpha]

Merck & Company, Inc. (new)  (MRK) 
Last merck & company, inc. (new) earnings: 4/28 06:45 am Check Earnings Report
US:NYSE Investor Relations: investors.merck.com/home/default.aspx
PDF full-year outlook amid ~20% YoY growth in sales for its blockbuster cancer medicine Keytruda. Merck's ( MRK ) Q1 sales reached $15.8B, with ~9% YoY growth on a reporte [Read more]